There are many innovations concerning the two branches of interventional cardiology. Coronary intervention focuses, especially in young patients, on bio-absorbable stents. Concerning structural heart disease intervention, there seems to be a new worldwide trend, particularly in patients with valvular heart disease, to be treated with percutaneous intervention.
There are many innovations concerning the two branches of interventional cardiology. Coronary intervention focuses, especially in young patients, on bio-absorbable stents. Concerning structural heart disease intervention, there seems to be a new worldwide trend, particularly in patients with valvular heart disease, to be treated with percutaneous intervention.
Professor Emeritus of Cardiology, University of Catania, General Director and Head of Thoracovascular, Morgagni Heart Center, Catania
Disease: Coronary disease , Aortic valve (stenosis) , Mitral valve insufficiency
Specialties: Cardiology , Interventional Cardiology
Tags: Angioplasty , DES (Drug Eluting Stent) , Bioadsorbible Coronary Stent , TAVI (Transcatheter Aortic Valve Implantation)
JIM 2013 - Joint Interventional Meeting


The focus is on structural heart problems


Innovations in interventional cardiology


What has changed in interventional cardiology in the USA


IVUS vs. FFR: which is the best tool for assessment


How to deal with the limitations of drug eluting stents


Hemodynamics: multidisciplinary evolution


Lower limb arterial disease:the drug eluting balloon


Scientific Societies: optimisation of economic resources


Coronary & Vascular interventional cardiology


Structural interventional cardiology


Cerebral protection during valve implantation


Artic stenosis: new devices


Mitral regurgitation: new percutaneous techniques

